Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: Results from APL 93 trial

Leukemia

Volumn 17, Issue 2, 2003, Pages 339-342

  de Botton, S ^b   Chevret, S ^b   Coiteux, V ^b   Dombret, H ^b   Sanz, M ^b   San Miguel, J ^b   Caillot, D ^b   Vekhoff, A ^b   Gardembas, M ^b   Stamatoulas, A ^b   Conde, E ^b   Guerci, A ^b,b   Gardin, C ^b,b   Fey, M ^b   Cony Makhoul, D ^b   Reman, O ^b,b   de la Serna, J ^b   Lefrere, F ^b   Chomienne, C ^b   Degos, L ^b   Fenaux, P ^a   Castaigne, S ^b   Zittoun, R ^b   Archimbaud, E ^b   Travade, P ^b   Stoppa, A M ^b   Dreyfus, F ^b   Stamatoulas, F ^b   Rigal Huguet, F ^b   Guy, H ^b   Sotto, J J ^b   Maloisel, F ^b   Reiffers, J ^b   Gardembas, A ^b   Bordessoule, D ^b   Fegueux, N ^b   Veil, A ^b   Lamy, T ^b   Hayat, M ^b   Deconinck, E ^b   Guyotat, E ^b   Martin, M ^b   Cony Makhoul, E ^b   Abgrall, J P ^b   Desablens, B ^b   Harousseau, J L ^b   Bastion, Y ^b   Pollet, J P ^b   more..

^a AVICENNE HOSPITAL   (France)

^b NONE

Author keywords

Acute promyelocytic leukemia; ATRA syndrome; Prophylaxis chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID; STEROID;

ADULT; AGED; ARTICLE; BODY WEIGHT DISORDER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; HYPOTENSION; INCIDENCE; KIDNEY FAILURE; LEUKOCYTE COUNT; LEUKOPENIA; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; SYNDROME;

EID: 0037328499     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402807     Document Type: Article

References (24)

1. Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 2002; 99: 759-767.
2. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L. A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1999; 94: 1192-1200.
3. Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X, Sanz M, Link H, Maloisel F, Gardin C, Bordessoule D, Stoppa AM, Sadoun A, Muus P, Wandt H, Mineur P, Whittaker JA, Fey M, Daniel MT, Castaigne S, Degos L. Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia 2000; 14: 1371.
4. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 1997; 90: 1014-1020.
5. Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemiatreated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood 1999; 93: 4131-4143.
6. Tallman M, Andersen J, Schiffer C, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH. All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 1021.
7. Sanz MA, Martin G, Rayon C, Esteve J, Gonzalez M, Diaz-Mediavilla J, Bolufer P, Barragan E, Terol MJ, Gonzalez JD, Colomer D, Chillon C, Rivas C, Gomez T, Ribera JM, Bornstein R, Roman J, Calasanz MJ, Arias J, Alvarez C, Ramos F, Deben G. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR-alpha-positive acute promyelocytic leukemia. Blood 1999; 94: 3015-3021.
8. Dubois C, Schlageter MH, De Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C. Modulation of II-8 and II-Ib and G-CSF secretion by all trans retinoic acid in acute promyelocytic leukemia. Leukemia 1994; 8: 1750.
9. De Gentile A, Toubert ME, Dubois C, Krawice I, Schlageter MH, Balitrand N, Castaigne S, Degos L, Rain JD, Najean Y, Chomienne C. Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia. Leukemia 1994; 8: 1758.
10. Marchetti M, Falanga A, Giovanelli S, Oldani E, Barbui T. All-trans retinoic acid increases adhesion to endothelium of the human APML cell line NB4. Br J Haematol 1996; 93: 360-366.
11. Di Noto R, Schiavone EM, Ferrara F, Manzo Lo Pardo C, Del Vecchio L. All-trans retinoic promotes a differential regulation of adhesion molecules on acute myeloid blast cells. Br J Haematol 1996; 88: 247-255.
12. Brown DC, Tsuji H, Larson RS. All-trans retinoic acid regulates adhesion mechanism and transmigration of the acute promyelocytic leukemia cell line NB-4 under physiologic flow. Br J Haematol 1999; 107: 86-98.
13. Larson RS, Brown DC, Sklar LA. Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB4 by utilization of LFA-1 and ICAM-2. Blood 1997; 90: 2747-2756.
14. De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Conde E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P. Incidence, clinical features, and outcome of all-trans retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1998; 92: 2712-2718.
15. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, François C, Larson RS, Wiernik PH. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 2000; 95: 90-95.
16. Frankel SR, Eardley A, Heller G, Berman E, Miller WH, Dimitrovsky E, Warrell RP. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann Intern Med 1994; 120: 279.
17. Vahdat L, Maslak P, Miller WH, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994; 84: 3843.
18. Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama K, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake S, Suzushima H, Emi N, Ohno R. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. J Clin Oncol 1998; 16: 78-85
19. Firkin FC, Mathews JP, Bradstock KF, Wiley JS. A phase II study of all-trans retinoic acid (ATRA) with prednisone prophylaxis in the treatment of acute promyelocytic leukemia (APL). Proc Am Soc Clin Oncol 1999; 94: 4225a (Abstr.).
20. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell R. The 'retinoic acid syndrome' in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292.
21. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
22. Cox DR. Regression models and life-tables (with discussion). JR Stat Soc B 1972; 34: 48.
23. Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). JR Stat Soc A 1972; 135: 185.
24. Fenaux P, Castaigne S, Chomienne C, Dombret H, Degos L. All-trans retinoic acid treatment for patients with acute promyelocytic leukemia. Leukemia 1992; 6 (Suppl. 1): 64-66.